Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 47 | 2023 | 1263 | 6.850 |
Why?
|
Heart Septum | 10 | 2021 | 313 | 2.130 |
Why?
|
Cardiac Surgical Procedures | 9 | 2023 | 3526 | 1.020 |
Why?
|
Ethanol | 7 | 2023 | 1337 | 1.000 |
Why?
|
Ventricular Outflow Obstruction | 4 | 2023 | 271 | 0.990 |
Why?
|
Myocardial Contraction | 19 | 2001 | 1585 | 0.740 |
Why?
|
Solvents | 2 | 2018 | 302 | 0.670 |
Why?
|
Ablation Techniques | 2 | 2019 | 249 | 0.670 |
Why?
|
Heart Failure | 29 | 2023 | 10856 | 0.640 |
Why?
|
Nitroprusside | 15 | 2001 | 275 | 0.630 |
Why?
|
Sclerosing Solutions | 3 | 2006 | 78 | 0.620 |
Why?
|
Blood Proteins | 4 | 2021 | 1122 | 0.620 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2021 | 859 | 0.510 |
Why?
|
Hemodynamics | 27 | 2019 | 4197 | 0.510 |
Why?
|
Atrial Natriuretic Factor | 6 | 1994 | 393 | 0.460 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2019 | 1527 | 0.460 |
Why?
|
Metabolome | 1 | 2020 | 881 | 0.460 |
Why?
|
Diastole | 11 | 1994 | 791 | 0.450 |
Why?
|
Proteomics | 6 | 2023 | 3618 | 0.410 |
Why?
|
Metabolomics | 1 | 2020 | 1467 | 0.400 |
Why?
|
Losartan | 1 | 2013 | 298 | 0.400 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 453 | 0.370 |
Why?
|
Echocardiography | 11 | 2018 | 5097 | 0.370 |
Why?
|
Atrioventricular Block | 2 | 2023 | 120 | 0.350 |
Why?
|
Mitral Valve | 4 | 2019 | 1484 | 0.300 |
Why?
|
Aortic Valve Insufficiency | 1 | 2011 | 577 | 0.290 |
Why?
|
Sinus of Valsalva | 1 | 2007 | 58 | 0.290 |
Why?
|
Cardiac Tamponade | 2 | 2006 | 173 | 0.290 |
Why?
|
Heart Ventricles | 11 | 2023 | 3801 | 0.280 |
Why?
|
Pericardiocentesis | 1 | 2006 | 74 | 0.280 |
Why?
|
Nicardipine | 3 | 1991 | 59 | 0.280 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2006 | 2059 | 0.260 |
Why?
|
Myocardium | 5 | 2021 | 4775 | 0.250 |
Why?
|
Sclerotherapy | 1 | 2006 | 175 | 0.250 |
Why?
|
Coronary Disease | 8 | 2002 | 6078 | 0.250 |
Why?
|
Animals, Domestic | 1 | 2004 | 56 | 0.250 |
Why?
|
Cat Diseases | 1 | 2004 | 35 | 0.250 |
Why?
|
Mitral Valve Stenosis | 2 | 2002 | 376 | 0.250 |
Why?
|
Exercise | 2 | 2020 | 5611 | 0.250 |
Why?
|
Heart | 8 | 2022 | 4462 | 0.240 |
Why?
|
Heart Block | 1 | 2005 | 410 | 0.240 |
Why?
|
Sequoia | 1 | 2023 | 6 | 0.240 |
Why?
|
Ferricyanides | 3 | 1989 | 32 | 0.240 |
Why?
|
Aortic Rupture | 1 | 2007 | 310 | 0.230 |
Why?
|
Stroke Volume | 12 | 2008 | 4983 | 0.230 |
Why?
|
Coronary Vessels | 4 | 2015 | 3099 | 0.230 |
Why?
|
Ancillary Services, Hospital | 1 | 2002 | 23 | 0.220 |
Why?
|
Humans | 112 | 2023 | 742088 | 0.220 |
Why?
|
Aortic Aneurysm | 2 | 2007 | 643 | 0.220 |
Why?
|
Pulmonary Wedge Pressure | 4 | 2018 | 264 | 0.210 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2012 | 846 | 0.200 |
Why?
|
Tricuspid Valve Stenosis | 1 | 2001 | 32 | 0.200 |
Why?
|
Middle Aged | 61 | 2023 | 213127 | 0.200 |
Why?
|
Coronary Angiography | 6 | 2020 | 4567 | 0.190 |
Why?
|
Coronary Care Units | 1 | 2002 | 214 | 0.190 |
Why?
|
Utilization Review | 1 | 2002 | 392 | 0.190 |
Why?
|
Aortic Valve Stenosis | 7 | 1992 | 1941 | 0.190 |
Why?
|
Informed Consent | 1 | 2007 | 991 | 0.190 |
Why?
|
Systole | 12 | 1998 | 956 | 0.190 |
Why?
|
Disopyramide | 2 | 2023 | 16 | 0.190 |
Why?
|
Cardiac Output, Low | 2 | 1992 | 193 | 0.180 |
Why?
|
Norepinephrine | 4 | 2019 | 909 | 0.180 |
Why?
|
American Heart Association | 4 | 2011 | 1055 | 0.180 |
Why?
|
Predictive Value of Tests | 6 | 2023 | 15056 | 0.180 |
Why?
|
Male | 68 | 2023 | 349538 | 0.170 |
Why?
|
Blood Volume | 3 | 1990 | 565 | 0.170 |
Why?
|
Pacemaker, Artificial | 3 | 2018 | 817 | 0.170 |
Why?
|
Case-Control Studies | 7 | 2023 | 21719 | 0.170 |
Why?
|
Unnecessary Procedures | 1 | 2002 | 431 | 0.160 |
Why?
|
Cardiovascular Agents | 2 | 2020 | 848 | 0.160 |
Why?
|
Aged | 45 | 2023 | 162944 | 0.160 |
Why?
|
Least-Squares Analysis | 1 | 2019 | 379 | 0.160 |
Why?
|
Exercise Test | 3 | 2021 | 2075 | 0.160 |
Why?
|
Ventricular Function, Left | 5 | 1998 | 3656 | 0.160 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2012 | 1873 | 0.160 |
Why?
|
Bioprosthesis | 1 | 2002 | 596 | 0.150 |
Why?
|
Myocardial Infarction | 5 | 2016 | 11690 | 0.150 |
Why?
|
Female | 63 | 2023 | 379592 | 0.150 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2001 | 346 | 0.150 |
Why?
|
Diagnostic Tests, Routine | 1 | 2002 | 783 | 0.140 |
Why?
|
Cardiotonic Agents | 5 | 1992 | 535 | 0.140 |
Why?
|
Coronary Artery Disease | 3 | 2020 | 6454 | 0.140 |
Why?
|
Iatrogenic Disease | 1 | 2019 | 545 | 0.140 |
Why?
|
Alcohols | 1 | 2016 | 92 | 0.140 |
Why?
|
Electrocardiography | 3 | 2008 | 6440 | 0.130 |
Why?
|
Vasodilator Agents | 5 | 1998 | 976 | 0.130 |
Why?
|
Epinephrine | 1 | 2019 | 793 | 0.130 |
Why?
|
Aptamers, Nucleotide | 1 | 2016 | 166 | 0.130 |
Why?
|
Stents | 2 | 2004 | 3276 | 0.120 |
Why?
|
Dobutamine | 2 | 1992 | 123 | 0.120 |
Why?
|
Blood Pressure | 13 | 2004 | 8541 | 0.120 |
Why?
|
Echocardiography, Doppler | 4 | 2011 | 934 | 0.120 |
Why?
|
Computers, Handheld | 1 | 2015 | 208 | 0.120 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 944 | 0.110 |
Why?
|
Nifedipine | 3 | 2001 | 226 | 0.110 |
Why?
|
Heart Valve Prosthesis | 3 | 2019 | 1486 | 0.110 |
Why?
|
Adult | 35 | 2023 | 213712 | 0.110 |
Why?
|
Dyspnea | 2 | 2015 | 1298 | 0.110 |
Why?
|
Ventricular Function | 3 | 2008 | 416 | 0.110 |
Why?
|
Shock | 2 | 2006 | 318 | 0.110 |
Why?
|
Exercise Therapy | 1 | 2019 | 904 | 0.100 |
Why?
|
Catheter Ablation | 4 | 2017 | 2746 | 0.100 |
Why?
|
Pressure | 4 | 2006 | 1203 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1067 | 0.100 |
Why?
|
Bundle-Branch Block | 1 | 2013 | 270 | 0.100 |
Why?
|
Peptide Mapping | 1 | 2011 | 263 | 0.100 |
Why?
|
Calcium Channel Blockers | 2 | 2012 | 689 | 0.100 |
Why?
|
Referral and Consultation | 2 | 2015 | 3527 | 0.100 |
Why?
|
Anesthesia, Epidural | 1 | 2013 | 227 | 0.090 |
Why?
|
Imidazoles | 2 | 1987 | 1205 | 0.090 |
Why?
|
Ventricular Septum | 2 | 2008 | 73 | 0.090 |
Why?
|
Models, Genetic | 1 | 2021 | 3493 | 0.090 |
Why?
|
Coronary Artery Bypass | 1 | 2020 | 2281 | 0.090 |
Why?
|
Nitric Oxide | 2 | 2001 | 2128 | 0.090 |
Why?
|
Cardiology Service, Hospital | 1 | 2012 | 246 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1952 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 3 | 2022 | 1541 | 0.090 |
Why?
|
Contrast Media | 1 | 2023 | 5295 | 0.090 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 440 | 0.090 |
Why?
|
Aged, 80 and over | 13 | 2021 | 57683 | 0.090 |
Why?
|
Heart Function Tests | 1 | 1990 | 330 | 0.080 |
Why?
|
Prospective Studies | 9 | 2023 | 53187 | 0.080 |
Why?
|
Anabolic Agents | 1 | 2011 | 247 | 0.080 |
Why?
|
Cardiovascular Diseases | 2 | 2021 | 15108 | 0.080 |
Why?
|
Treatment Failure | 2 | 2006 | 2615 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2527 | 0.080 |
Why?
|
Chest Pain | 1 | 2015 | 1113 | 0.080 |
Why?
|
Tomography, Emission-Computed | 1 | 1991 | 1144 | 0.080 |
Why?
|
Vascular Surgical Procedures | 1 | 2017 | 1473 | 0.080 |
Why?
|
Treatment Outcome | 8 | 2020 | 62966 | 0.080 |
Why?
|
Genetic Testing | 1 | 2021 | 3439 | 0.080 |
Why?
|
Heart Diseases | 4 | 2015 | 2789 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 4929 | 0.080 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2008 | 110 | 0.080 |
Why?
|
Cardiac Output | 3 | 1991 | 853 | 0.080 |
Why?
|
Fabry Disease | 1 | 2008 | 90 | 0.080 |
Why?
|
Quinolines | 1 | 1992 | 719 | 0.080 |
Why?
|
Tachycardia | 1 | 1989 | 620 | 0.070 |
Why?
|
Aortic Valve | 3 | 1992 | 1911 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3731 | 0.070 |
Why?
|
Risk Factors | 11 | 2022 | 72145 | 0.070 |
Why?
|
Anti-Infective Agents, Local | 1 | 2009 | 250 | 0.070 |
Why?
|
Tachycardia, Sinus | 1 | 2006 | 42 | 0.070 |
Why?
|
Magnetic Resonance Angiography | 1 | 2013 | 1440 | 0.070 |
Why?
|
Fibrosis | 1 | 2013 | 2026 | 0.070 |
Why?
|
Heart Injuries | 1 | 2008 | 209 | 0.070 |
Why?
|
Health Status | 2 | 2020 | 4030 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2012 | 1239 | 0.070 |
Why?
|
Genotype | 1 | 2021 | 12946 | 0.070 |
Why?
|
Ventricular Fibrillation | 1 | 2009 | 538 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4214 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 1987 | 215 | 0.070 |
Why?
|
Cats | 2 | 2004 | 998 | 0.070 |
Why?
|
Creatine Kinase | 2 | 2004 | 694 | 0.070 |
Why?
|
Hemangiosarcoma | 1 | 1988 | 236 | 0.070 |
Why?
|
Enoximone | 3 | 1993 | 9 | 0.070 |
Why?
|
Anesthesia, General | 1 | 2013 | 1164 | 0.070 |
Why?
|
Injections, Intralesional | 1 | 2006 | 276 | 0.070 |
Why?
|
Vascular Resistance | 4 | 1994 | 936 | 0.060 |
Why?
|
Natriuretic Peptides | 1 | 2006 | 150 | 0.060 |
Why?
|
Boston | 4 | 2020 | 9305 | 0.060 |
Why?
|
Heart Neoplasms | 1 | 1988 | 374 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39004 | 0.060 |
Why?
|
Cardiology | 1 | 2015 | 1658 | 0.060 |
Why?
|
Abscess | 1 | 2008 | 607 | 0.060 |
Why?
|
Heart Atria | 2 | 2007 | 1348 | 0.060 |
Why?
|
Creatine Kinase, MB Form | 1 | 2004 | 214 | 0.060 |
Why?
|
Syncope | 2 | 2005 | 429 | 0.060 |
Why?
|
Medical Oncology | 1 | 2015 | 2235 | 0.060 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2203 | 0.060 |
Why?
|
Neurosecretory Systems | 1 | 1985 | 231 | 0.060 |
Why?
|
Heart Murmurs | 1 | 2003 | 94 | 0.060 |
Why?
|
Catheterization | 1 | 1988 | 1468 | 0.060 |
Why?
|
Mitral Valve Insufficiency | 2 | 2007 | 1415 | 0.050 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2023 | 790 | 0.050 |
Why?
|
Angina Pectoris | 1 | 1986 | 977 | 0.050 |
Why?
|
Safety | 1 | 2007 | 1185 | 0.050 |
Why?
|
Gated Blood-Pool Imaging | 2 | 1992 | 44 | 0.050 |
Why?
|
Pilot Projects | 2 | 2013 | 8297 | 0.050 |
Why?
|
Aortic Diseases | 1 | 2008 | 741 | 0.050 |
Why?
|
Forms and Records Control | 1 | 2002 | 160 | 0.050 |
Why?
|
Retrospective Studies | 11 | 2021 | 77098 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2008 | 834 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 2 | 2009 | 2267 | 0.050 |
Why?
|
Cardiomyopathy, Dilated | 3 | 1998 | 851 | 0.050 |
Why?
|
Blood Gas Analysis | 1 | 2002 | 381 | 0.050 |
Why?
|
Software | 1 | 2015 | 4434 | 0.050 |
Why?
|
Choice Behavior | 1 | 2007 | 802 | 0.050 |
Why?
|
Infusions, Intravenous | 3 | 2001 | 2271 | 0.050 |
Why?
|
Proteome | 1 | 2011 | 1790 | 0.050 |
Why?
|
Isoenzymes | 3 | 2004 | 1725 | 0.050 |
Why?
|
Surgical Procedures, Operative | 1 | 2013 | 1873 | 0.050 |
Why?
|
Total Quality Management | 1 | 2002 | 274 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7276 | 0.050 |
Why?
|
Tachycardia, Ventricular | 1 | 2009 | 1272 | 0.050 |
Why?
|
Statistics, Nonparametric | 1 | 2006 | 2885 | 0.050 |
Why?
|
Pyridones | 4 | 1986 | 712 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2001 | 15244 | 0.040 |
Why?
|
Troponin T | 1 | 2004 | 749 | 0.040 |
Why?
|
Peptide Fragments | 2 | 2006 | 5095 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2006 | 1573 | 0.040 |
Why?
|
Blood Flow Velocity | 4 | 1994 | 1423 | 0.040 |
Why?
|
Societies, Medical | 4 | 2011 | 3740 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2021 | 1869 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2013 | 12017 | 0.040 |
Why?
|
Cardiomyopathies | 1 | 2011 | 1912 | 0.040 |
Why?
|
Biopsy | 1 | 2011 | 6756 | 0.040 |
Why?
|
Pulmonary Ventilation | 1 | 2021 | 372 | 0.040 |
Why?
|
New York | 1 | 2021 | 886 | 0.040 |
Why?
|
Reoperation | 2 | 2003 | 4200 | 0.040 |
Why?
|
Heart Rate | 4 | 2019 | 4091 | 0.040 |
Why?
|
Time Factors | 7 | 2020 | 40054 | 0.040 |
Why?
|
Gadolinium | 1 | 2023 | 951 | 0.040 |
Why?
|
Hospitals, Teaching | 1 | 2002 | 1179 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2006 | 6365 | 0.040 |
Why?
|
Disease Management | 1 | 2008 | 2450 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2001 | 592 | 0.040 |
Why?
|
Prognosis | 6 | 2021 | 29010 | 0.040 |
Why?
|
Death | 1 | 2021 | 675 | 0.040 |
Why?
|
Cardiomegaly | 3 | 1985 | 619 | 0.040 |
Why?
|
Administration, Inhalation | 2 | 2001 | 1104 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 35342 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9410 | 0.030 |
Why?
|
Signal Transduction | 3 | 2023 | 23387 | 0.030 |
Why?
|
Recurrence | 2 | 2008 | 8333 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2002 | 2110 | 0.030 |
Why?
|
Intensive Care Units | 2 | 2006 | 3679 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 846 | 0.030 |
Why?
|
Risk Assessment | 3 | 2021 | 23320 | 0.030 |
Why?
|
Acute Disease | 3 | 2021 | 7141 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1771 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 2016 | 353 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 1979 | 1684 | 0.030 |
Why?
|
Hypertension | 1 | 1994 | 8455 | 0.030 |
Why?
|
Kidney | 1 | 1990 | 7167 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 950 | 0.030 |
Why?
|
Atrial Function | 1 | 1994 | 107 | 0.030 |
Why?
|
Program Evaluation | 1 | 2002 | 2485 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1483 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3528 | 0.030 |
Why?
|
United States | 6 | 2019 | 69693 | 0.030 |
Why?
|
Ultrasonography | 2 | 2005 | 5978 | 0.030 |
Why?
|
Critical Illness | 1 | 2006 | 2665 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2020 | 1503 | 0.030 |
Why?
|
Mathematical Computing | 1 | 1992 | 147 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 977 | 0.030 |
Why?
|
Cause of Death | 2 | 2001 | 3571 | 0.030 |
Why?
|
Lisinopril | 1 | 2011 | 54 | 0.030 |
Why?
|
Algorithms | 1 | 2012 | 13853 | 0.030 |
Why?
|
Pulmonary Circulation | 1 | 1994 | 739 | 0.030 |
Why?
|
Vasoconstriction | 1 | 1994 | 596 | 0.030 |
Why?
|
Atrial Function, Right | 1 | 1991 | 33 | 0.020 |
Why?
|
Critical Care | 1 | 2004 | 2640 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2016 | 19862 | 0.020 |
Why?
|
Phenotype | 2 | 2021 | 16331 | 0.020 |
Why?
|
Hospitals, General | 1 | 2015 | 749 | 0.020 |
Why?
|
Radiography | 1 | 2002 | 7010 | 0.020 |
Why?
|
Furosemide | 1 | 2011 | 167 | 0.020 |
Why?
|
Registries | 2 | 2019 | 8077 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2706 | 0.020 |
Why?
|
Adolescent | 4 | 2006 | 85649 | 0.020 |
Why?
|
Diagnosis, Differential | 4 | 2011 | 12958 | 0.020 |
Why?
|
Myocardial Reperfusion | 1 | 1991 | 351 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2016 | 1157 | 0.020 |
Why?
|
Natriuresis | 1 | 1990 | 124 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2001 | 1527 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2857 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 1998 | 1175 | 0.020 |
Why?
|
Actuarial Analysis | 1 | 1989 | 377 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2593 | 0.020 |
Why?
|
Survival Analysis | 4 | 2009 | 10248 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 1994 | 770 | 0.020 |
Why?
|
Systems Integration | 1 | 2011 | 440 | 0.020 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 1989 | 60 | 0.020 |
Why?
|
Catecholamines | 1 | 1989 | 387 | 0.020 |
Why?
|
Isotopes | 1 | 2008 | 123 | 0.020 |
Why?
|
Survival Rate | 2 | 2001 | 12773 | 0.020 |
Why?
|
Diuretics | 1 | 2011 | 591 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 1988 | 415 | 0.020 |
Why?
|
Coronary Circulation | 2 | 1998 | 1572 | 0.020 |
Why?
|
Emergency Treatment | 1 | 2012 | 517 | 0.020 |
Why?
|
Coronary Sinus | 1 | 2008 | 87 | 0.020 |
Why?
|
Advisory Committees | 1 | 2011 | 773 | 0.020 |
Why?
|
Lactates | 1 | 1988 | 432 | 0.020 |
Why?
|
Elasticity | 1 | 1989 | 657 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2002 | 4369 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2001 | 5310 | 0.020 |
Why?
|
Rheology | 1 | 1987 | 345 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 21596 | 0.020 |
Why?
|
Nitroglycerin | 1 | 1987 | 325 | 0.020 |
Why?
|
Internal Mammary-Coronary Artery Anastomosis | 1 | 1986 | 33 | 0.020 |
Why?
|
Renin | 1 | 1988 | 642 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2007 | 364 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3339 | 0.020 |
Why?
|
Jogging | 1 | 2005 | 18 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1987 | 637 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1998 | 4455 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 5062 | 0.020 |
Why?
|
Sotalol | 1 | 2005 | 49 | 0.020 |
Why?
|
Debridement | 1 | 2008 | 492 | 0.020 |
Why?
|
Metoprolol | 1 | 2005 | 93 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 1990 | 994 | 0.020 |
Why?
|
Reference Standards | 1 | 2008 | 1020 | 0.020 |
Why?
|
Milrinone | 4 | 1986 | 84 | 0.020 |
Why?
|
Regression Analysis | 1 | 1994 | 6452 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15194 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1517 | 0.020 |
Why?
|
Pericardium | 1 | 1989 | 667 | 0.020 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2004 | 86 | 0.010 |
Why?
|
Aldosterone | 1 | 1988 | 876 | 0.010 |
Why?
|
Unconsciousness | 1 | 2005 | 262 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9846 | 0.010 |
Why?
|
Acute Coronary Syndrome | 1 | 2016 | 2337 | 0.010 |
Why?
|
Postoperative Period | 1 | 1987 | 1839 | 0.010 |
Why?
|
Kinetics | 2 | 2008 | 6474 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10232 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1989 | 10943 | 0.010 |
Why?
|
Administration, Sublingual | 1 | 2001 | 56 | 0.010 |
Why?
|
Heart Transplantation | 1 | 1994 | 3119 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14720 | 0.010 |
Why?
|
Vasodilation | 2 | 2001 | 944 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13403 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 13921 | 0.010 |
Why?
|
Aorta | 1 | 2008 | 2057 | 0.010 |
Why?
|
Dogs | 1 | 1985 | 3910 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2008 | 1636 | 0.010 |
Why?
|
Defibrillators, Implantable | 1 | 2009 | 1440 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3611 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4771 | 0.010 |
Why?
|
Animals | 5 | 2008 | 168561 | 0.010 |
Why?
|
Chronic Disease | 1 | 1994 | 9144 | 0.010 |
Why?
|
Erythrocyte Aging | 1 | 1979 | 52 | 0.010 |
Why?
|
Glucose | 1 | 1991 | 4391 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5019 | 0.010 |
Why?
|
Radionuclide Imaging | 3 | 1989 | 2027 | 0.010 |
Why?
|
Preoperative Care | 1 | 1987 | 2245 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1998 | 231 | 0.010 |
Why?
|
Laser-Doppler Flowmetry | 1 | 1998 | 242 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15530 | 0.010 |
Why?
|
Erythrocyte Membrane | 1 | 1979 | 442 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 1979 | 514 | 0.010 |
Why?
|
Acetylcholine | 1 | 1998 | 621 | 0.010 |
Why?
|
Hemin | 1 | 1975 | 49 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1986 | 3760 | 0.010 |
Why?
|
Erythrocytes | 2 | 1989 | 2452 | 0.010 |
Why?
|
Radionuclide Angiography | 1 | 1994 | 23 | 0.010 |
Why?
|
Reticulocytes | 1 | 1975 | 290 | 0.010 |
Why?
|
Cohort Studies | 2 | 2009 | 40450 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12344 | 0.010 |
Why?
|
Heme | 1 | 1975 | 307 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1989 | 4229 | 0.010 |
Why?
|
Adenosine | 1 | 1998 | 823 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19223 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13655 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 56350 | 0.010 |
Why?
|
Rats | 1 | 2008 | 24265 | 0.010 |
Why?
|
Pericardial Effusion | 1 | 1994 | 246 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1975 | 1470 | 0.010 |
Why?
|
Massachusetts | 1 | 2004 | 8662 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12242 | 0.010 |
Why?
|
Technetium | 1 | 1989 | 334 | 0.010 |
Why?
|
Protein Kinases | 1 | 1975 | 1638 | 0.010 |
Why?
|
Drainage | 1 | 1994 | 1140 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1975 | 2126 | 0.000 |
Why?
|
Age Factors | 1 | 1985 | 18355 | 0.000 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1994 | 1538 | 0.000 |
Why?
|
Stimulation, Chemical | 1 | 1986 | 326 | 0.000 |
Why?
|
Citrate (si)-Synthase | 1 | 1985 | 43 | 0.000 |
Why?
|
Risk | 1 | 1998 | 9679 | 0.000 |
Why?
|
Constriction, Pathologic | 1 | 1989 | 1095 | 0.000 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1985 | 424 | 0.000 |
Why?
|
Aortography | 1 | 1986 | 431 | 0.000 |
Why?
|
Cardiac Volume | 1 | 1984 | 210 | 0.000 |
Why?
|
Creatine | 1 | 1985 | 421 | 0.000 |
Why?
|
Angiography | 1 | 1989 | 1636 | 0.000 |
Why?
|
Aorta, Abdominal | 1 | 1986 | 645 | 0.000 |
Why?
|
Child, Preschool | 1 | 1985 | 40955 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1998 | 9941 | 0.000 |
Why?
|
Blood Vessel Prosthesis | 1 | 1986 | 933 | 0.000 |
Why?
|
Enzyme Activation | 2 | 1979 | 3701 | 0.000 |
Why?
|
Rabbits | 2 | 1979 | 4886 | 0.000 |
Why?
|
Nucleotidases | 1 | 1979 | 31 | 0.000 |
Why?
|
Acetylcholinesterase | 1 | 1979 | 153 | 0.000 |
Why?
|
Ouabain | 1 | 1979 | 264 | 0.000 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1985 | 1504 | 0.000 |
Why?
|
Membrane Lipids | 1 | 1979 | 248 | 0.000 |
Why?
|
Child | 1 | 1985 | 77478 | 0.000 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1979 | 494 | 0.000 |
Why?
|
Magnesium | 1 | 1979 | 813 | 0.000 |
Why?
|
Phospholipids | 1 | 1979 | 781 | 0.000 |
Why?
|
Adenosine Triphosphatases | 1 | 1979 | 836 | 0.000 |
Why?
|
Cyclic GMP | 1 | 1975 | 408 | 0.000 |
Why?
|
Macromolecular Substances | 1 | 1975 | 1456 | 0.000 |
Why?
|
Calcium | 1 | 1985 | 5753 | 0.000 |
Why?
|
Glycoproteins | 1 | 1979 | 2260 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1986 | 7901 | 0.000 |
Why?
|
Binding Sites | 1 | 1975 | 6115 | 0.000 |
Why?
|
Protein Binding | 1 | 1975 | 9387 | 0.000 |
Why?
|
Membrane Proteins | 1 | 1979 | 7873 | 0.000 |
Why?
|